Figure 1. Chemical structures of compounds tested as EYA3 inhibitors and anti-angiogenic agents.
(A) Metabolites of BBR. (B) Alternate halogenation of the phenol ring. (C) Alternate substituents at position 2 of the benzofuran.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.